Ariad Pharmaceuticals, Inc. to Present at the UBS Global Life Sciences Conference
Published: Sep 12, 2012
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the UBS Global Life Sciences conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business on Wednesday, September 19, 2012 at 9:00 a.m. (ET). The ARIAD presentation at the UBS Global Life Sciences Conference will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.